This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Janssen Biotech, Inc.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: **Natasa Obermajer: Innovating with HLA-G Antigen Binding Domains**
Introduction
Natasa Obermajer is an esteemed inventor based in Antwerp, Belgium, known for her innovative contributions to biotechnology. With a focus on human immunology, her work aims to advance the understanding and applications of critical immune system proteins.
Latest Patents
Natasa holds a significant patent titled "Proteins comprising HLA-G antigen binding domains and their uses." This invention revolves around the development of antigen binding domains that bind to the human leukocyte antigen G (HLA-G) protein. The patent also includes essential components like polynucleotides encoding the binding domains, vectors, host cells, and methods for their production and application.
Career Highlights
Currently, Natasa works at Janssen Biotech, Inc., a leading company in the field of biopharmaceuticals. Her research and innovation contribute to the development of breakthrough therapies that can enhance patient outcomes.
Collaborations
Throughout her career, Natasa has collaborated with notable coworkers such as Adam Zwolak and Sylvie Laquerre. These partnerships have allowed for a rich exchange of ideas and expertise, furthering the impact of her research in the scientific community.
Conclusion
Natasa Obermajer continues to make significant strides in the field of immunology through her patent on HLA-G antigen binding domains. Her innovative spirit and collaborative efforts position her as a key figure in advancing biotechnological research and applications in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile